2-Bromo-7-fluoro-[1,2,4]triazolo[1,5-a]pyridine

Catalog No.: 
ACQTEP496
CAS No.: 
2090398-13-1
Molecular Formula: 
C6H3BrFN3
Molecular Weight: 
216.01
2-Bromo-7-fluoro-[1,2,4]triazolo[1,5-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$101.00In stockInquiry
100mg95%$169.00In stockInquiry
250mg95%$203.00In stockInquiry
1g95%$777.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-7-fluoro-[1,2,4]triazolo[1,5-a]pyridine
IUPAC Name2-bromo-7-fluoro-[1,2,4]triazolo[1,5-a]pyridine
MDL No.MFCD30180135
Molecular FormulaC6H3BrFN3
Molecular Weight216.01
SMILESFC1=CC2=NC(Br)=NN2C=C1
InChI KeyJFUXQVUMKDPGJP-UHFFFAOYSA-N
Synonym[1,2,4]Triazolo[1,5-a]pyridine, 2-bromo-7-fluoro-
CAS No.2090398-13-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACQTEP496 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQTEP496 route compound structure diagram
    ACQTEP4962090398-13-1In Stock
  4. Then
  5. ACQTEP496 route product structure diagram
    ACQTEP4962090398-13-1In Stock
Inquiry

2. ACQTEP496 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQTEP496 route product structure diagram
    ACQTEP4962090398-13-1In Stock
Inquiry

3. ACQTEP496 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQTEP496 route product structure diagram
    ACQTEP4962090398-13-1In Stock
Inquiry

Comments (0)